Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03678870 · ClinicalTrials.gov registry record · NA

Discharge Opioid Education to Decrease Opioid Use After Cesarean

A NA study of Opioid Use, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
196
Enrollment target
1
Study location

NCT03678870 is a NA study of Opioid Use that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 196 participants, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03678870, a NA study of Opioid Use, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
196 participants
Enrollment target
1
Study location

Study Summary

Background: The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion and higher opioid use after surgery has been associated with an increased risk of chronic opioid use. Reducing the amount of opioid used after cesarean delivery may decrease the risk of chronic opioid use and will help towards better estimating and reducing the amount of opioids prescribed at discharge. Objective: To to compare discharge opioid education to standard care to ascertain whether opioid education reduces opioid use after hospital discharge

Conditions Studied

Opioid Use

Interventions

  • OTHER Opioid Education Handout

Study Locations (1)

Tennessee

  • Sarah Osmundson - Nashville

Trial Details

FieldValue
Enrollment Target 196 participants
Start Date 2018-09-01
Est. Completion 2019-11-01
Phase NA

Sponsor

Vanderbilt University Medical Center

677 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03678870

The ClinicalTrials.gov registry entry for NCT03678870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Opioid Education Handout is the first listed.

NCT03678870 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03678870 about?

NCT03678870 is a clinical study titled "Discharge Opioid Education to Decrease Opioid Use After Cesarean". Background: The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available...

What is the current status of trial NCT03678870?

This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2018-09-01. Estimated completion is 2019-11-01.

What conditions does trial NCT03678870 study?

This clinical trial studies the following conditions: Opioid Use.

What interventions are being tested in trial NCT03678870?

The interventions under investigation include: Opioid Education Handout (OTHER).

Who is sponsoring clinical trial NCT03678870?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03678870 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.